Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study

BACKGROUND AND OBJECTIVE: Prescribing inhaled corticosteroids (ICS) for bronchiectasis (BE) in the absence of obstructive lung disease is controversial. Studies investigating ICS therapy and impact on morbidity and mortality in BE are sparse. METHODS: This study comprises all patients with BE manage...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Chron Obstruct Pulmon Dis
Prif Awduron: Håkansson, Kjell E J, Fjaellegaard, Katrine, Browatzki, Andrea, Dönmez Sin, Melda, Ulrik, Charlotte Suppli
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove 2021
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8291380/
https://ncbi.nlm.nih.gov/pubmed/34295156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S311236
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg